Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10
Published September 18, 2019 · Recall initiated: August 21, 2019
Summary
FDA records drug Class III recall D-1851-2019, published September 18, 2019 and initiated August 21, 2019. Recalling firm: Macleods Pharma Usa Inc; Status: Terminated; Reported quantity: 1837 90-count bottles; Lot: Lot #BPA801A, EXP 12/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
What to do
Voluntary: Firm initiated · Letter
Get an email if PRAMIPEXOLE DIHYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PRAMIPEXOLE DIHYDROCHLORIDE
- Manufacturer
- Macleods Pharma Usa Inc
- Distributor
- Distributed Nationwide in the USA
- UPC
- 0333342031105
- Lot
- Lot #BPA801A, EXP 12/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged bySeptember 18, 2019
- FDABacteriostatic Water for Injection, USP, 30 mL vials, Rx only, Mfd. for: Hospira, Inc., Lake Forest, IL 60045September 18, 2019
- FDAGatifloxacin Ophthalmic Solution 0.5%, 2.5 mL per bottle, Rx Only, Mfd. for: Mylan Pharmaceuticals Inc.,September 18, 2019
- FDA10% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in a) 5ml, b) 10ml c) 15 ml, dropper bottlesSeptember 18, 2019
- FDALamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual DoseSeptember 18, 2019
- FDAMilk of Magnesia USP, 2400 mg/30 mL, Magnesium Hydroxide 2400 mg, 30 mL unit dose cups, For Institutional UseSeptember 18, 2019
Questions about this recall
Was Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10 recalled?
Yes. FDA published recall D-1851-2019 on September 18, 2019. Reported hazard: Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PRAMIPEXOLE DIHYDROCHLORIDE. UPC: 0333342031105.